# Immunogenicity of HPV Vaccine in Immunosuppressed Children

> **NCT02263703** · PHASE3 · COMPLETED · sponsor: **The University of New South Wales** · enrollment: 55 (actual)

## Conditions studied

- Autoimmune Disease
- Juvenile Idiopathic Arthritis
- Inflammatory Bowel Disease
- Evidence of Liver Transplantation
- Kidney Transplant Infection
- Bone Marrow Transplant Infection

## Interventions

- **BIOLOGICAL:** Quadrivalent HPV vaccine

## Key facts

- **NCT ID:** NCT02263703
- **Lead sponsor:** The University of New South Wales
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2016-02
- **Final completion:** 2016-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2024-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02263703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02263703, "Immunogenicity of HPV Vaccine in Immunosuppressed Children". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02263703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*